James M. Gower

James M. Gower is a declared insider at 2 companies; the most frequent names are Cell Genesys Inc and Rigel Pharmaceuticals Inc. We count 5 filings; the first trade dates from 2 November 2005 and the latest from 14 October 2009.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 15 October 2009 came the latest disclosure, a transaction in Cell Genesys Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.